The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -38.40%. However, over the past six months, we’ve seen a stronger performance of -67.51%. The price of ZURA fallen by 19.38% over the last 30 days. And in the last five days, it has surged by 6.94%.
The market performance of Zura Bio Ltd’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $6.35 on 05/17/24, while the lowest value for the same duration was $0.97 on 04/04/25.
52-week price history of ZURA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Zura Bio Ltd’s current trading price is -75.75% away from its 52-week high, while its distance from the 52-week low is 58.76%. The stock’s price range during this period has varied between$0.97 and $6.35. The Zura Bio Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 0.84 million for the day, a figure considerably higher than their average daily volume of 0.36 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Zura Bio Ltd (ZURA) has experienced a quarterly decline of -10.98% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 105.30M and boasts a workforce of 30 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.6871, with a change in price of -1.1600. Similarly, Zura Bio Ltd recorded 439,301 in trading volume during the last 100 days, posting a change of -42.96%.
ZURA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ZURA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
ZURA Stock Stochastic Average
As of today, Zura Bio Ltd’s raw stochastic average for the last 50 days stands at 80.21%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 80.21%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 72.97% and 70.38%, respectively.
